Clinical Trials Detail

Standard or Comprehensive Radiation in Patients With Previously Treated Early-Stage Breast Cancer

A Randomized Ph.3 Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

Objective
CategoryInformation
Study #: NSABP B-51
Anatomic Site:

Breast

Histology: Breast Cancer
Stage: Invasive Ductal, Invasive Lobular
Cancer:
  • Stage IB
  • Stage II
Treatment Phase: Patient must have clinically T1-3, NI breast cancer at time of diagnosis (before neoadjuvant therapy), estrogen receptor analysis performed before neoadjuvant chemotherapy, and must have completed a minimum of 12 weeks of standard neoadjuvant chemotherapy.
Location:
Study Link: https://clinicaltrials.gov/ct2/show/NCT01872975?term=NSABP+B-51&rank=1

Clinical Trial Categories

  • Breast